Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 31 studies | 28% ± 12% | |
smooth muscle cell | 21 studies | 28% ± 12% | |
pericyte | 15 studies | 26% ± 6% | |
basal cell | 14 studies | 35% ± 12% | |
epithelial cell | 11 studies | 37% ± 20% | |
connective tissue cell | 9 studies | 31% ± 7% | |
astrocyte | 9 studies | 25% ± 7% | |
endothelial cell | 8 studies | 21% ± 4% | |
club cell | 7 studies | 31% ± 5% | |
myofibroblast cell | 7 studies | 25% ± 8% | |
enterocyte | 7 studies | 62% ± 20% | |
glutamatergic neuron | 7 studies | 32% ± 17% | |
respiratory goblet cell | 6 studies | 38% ± 18% | |
secretory cell | 5 studies | 30% ± 7% | |
progenitor cell | 5 studies | 41% ± 18% | |
transit amplifying cell | 5 studies | 30% ± 10% | |
ciliated cell | 5 studies | 21% ± 6% | |
erythrocyte | 5 studies | 45% ± 20% | |
oligodendrocyte | 5 studies | 19% ± 4% | |
deuterosomal cell | 4 studies | 41% ± 5% | |
conventional dendritic cell | 4 studies | 28% ± 8% | |
goblet cell | 4 studies | 30% ± 10% | |
intestinal crypt stem cell | 4 studies | 44% ± 11% | |
brush cell | 4 studies | 29% ± 7% | |
mesothelial cell | 4 studies | 26% ± 4% | |
erythroblast | 4 studies | 45% ± 19% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 30% ± 9% | |
GABAergic neuron | 4 studies | 39% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
duct epithelial cell | 3 studies | 27% ± 4% | |
ionocyte | 3 studies | 31% ± 5% | |
non-classical monocyte | 3 studies | 21% ± 5% | |
enteroendocrine cell | 3 studies | 28% ± 10% | |
retinal ganglion cell | 3 studies | 52% ± 25% | |
myeloid cell | 3 studies | 21% ± 5% | |
retina horizontal cell | 3 studies | 29% ± 9% | |
mucus secreting cell | 3 studies | 26% ± 6% | |
serous secreting cell | 3 studies | 52% ± 1% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 1% | |
type I pneumocyte | 3 studies | 22% ± 6% | |
abnormal cell | 3 studies | 26% ± 4% | |
keratinocyte | 3 studies | 20% ± 2% | |
interneuron | 3 studies | 35% ± 15% | |
progenitor cell of mammary luminal epithelium | 3 studies | 37% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6565.05 | 459 / 459 | 100% | 203.35 | 1115 / 1118 |
brain | 100% | 6568.58 | 2636 / 2642 | 100% | 106.12 | 703 / 705 |
lung | 99% | 4211.00 | 575 / 578 | 100% | 121.70 | 1151 / 1155 |
esophagus | 100% | 6900.46 | 1445 / 1445 | 99% | 97.06 | 181 / 183 |
stomach | 100% | 4744.06 | 359 / 359 | 98% | 98.24 | 280 / 286 |
skin | 100% | 6485.52 | 1808 / 1809 | 98% | 94.66 | 461 / 472 |
adrenal gland | 100% | 11169.27 | 258 / 258 | 97% | 127.25 | 224 / 230 |
thymus | 100% | 4753.24 | 652 / 653 | 97% | 67.17 | 586 / 605 |
ovary | 100% | 7045.85 | 180 / 180 | 96% | 62.19 | 413 / 430 |
intestine | 100% | 9571.85 | 966 / 966 | 96% | 87.40 | 505 / 527 |
uterus | 100% | 6628.92 | 170 / 170 | 93% | 83.98 | 426 / 459 |
prostate | 100% | 5324.14 | 244 / 245 | 92% | 70.18 | 461 / 502 |
kidney | 100% | 3558.57 | 89 / 89 | 89% | 46.18 | 801 / 901 |
bladder | 100% | 4797.86 | 21 / 21 | 75% | 62.71 | 379 / 504 |
pancreas | 63% | 1040.71 | 206 / 328 | 96% | 73.18 | 170 / 178 |
liver | 90% | 3626.53 | 204 / 226 | 45% | 54.81 | 184 / 406 |
adipose | 100% | 4984.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8196.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2790.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 98.86 | 45 / 45 |
muscle | 98% | 2874.45 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 90% | 2351.77 | 777 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 62.24 | 72 / 80 |
lymph node | 0% | 0 | 0 / 0 | 79% | 35.64 | 23 / 29 |
peripheral blood | 67% | 1722.18 | 619 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019544 | Biological process | arginine catabolic process to glutamate |
GO_0007601 | Biological process | visual perception |
GO_0055129 | Biological process | L-proline biosynthetic process |
GO_0010121 | Biological process | arginine catabolic process to proline via ornithine |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0004587 | Molecular function | ornithine aminotransferase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
Gene name | OAT |
Protein name | Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form] |
Synonyms | |
Description | FUNCTION: Catalyzes the reversible interconversion of L-ornithine and 2-oxoglutarate to L-glutamate semialdehyde and L-glutamate. . |
Accessions | ENST00000539214.5 [P04181-2] ENST00000368845.6 [P04181-1] P04181 |